If you don’t see your condition listed,
Your (or your loved one’s) medical records contain clues that can lead to new treatments.
AllStripes researchers learn from patient records what would truly improve quality of life.
Using cutting-edge tech we analyze your community’s data to improve trial design and chances of success.
Your community’s de-identified records can advance multiple treatment studies.
We do the work to collect all your records, at no cost, in your secure account. Access doctors’ notes you’ve never seen.
See how your rare disease journey compares to others with your condition, and what’s helping.
We’ll send you exclusive updates on the studies you’re contributing to and how you’re driving forward research.
Onno Faber (Founder) & Nancy Yu (CEO)
AllStripes’ mission is to unlock new treatments for people with rare disease. About 1 in 10 people have a rare disease, and half are children.
AllStripes (formerly RDMD) was co-founded in 2017 by CEO Nancy Yu and Onno Faber, a rare disease patient deeply frustrated by the drug development process.
“I was diagnosed with a rare genetic disease and it completely changed my perspective,” Onno shares. “Patients can’t be bystanders in drug development.”
As the first and only research platform dedicated to rare diseases, AllStripes makes it easy for patients to contribute to new treatment studies from home. We do the work to collect and analyze your de-identified medical records to help power faster, better drug development for your condition.
The name AllStripes was inspired by the official symbol for the rare disease community, the zebra. When we come together and learn from each other’s experiences we can push for better treatments across all rare conditions.
AllStripes Announces Key Leadership Hires as Expansion and Growth AcceleratePress Release,September 28, 2021
AllStripes Announces $50 Million Series B FinancingPress Release,August 24, 2021
AllStripes expands rare disease research programs to United KingdomPress Release,February 12, 2021
AllStripes Announces Collaboration with Taysha Gene Therapies for SURF1-Associated Leigh Syndrome ProgramBusiness Wire,January 4, 2021
AllStripes Announces Partnership with Penn’s Orphan Disease CenterBusiness Wire,October 26, 2020
It’s official, RDMD has a new name: AllStripesPress Release,September 15, 2020